Can an asthma drug slow ALS? new trial aims to find out
Disease control
Recruiting now
This phase 2 trial is testing whether an inhaled drug called cromolyn (PHENOGENE-1A) can help people with mild-to-moderate ALS when added to standard care. About 105 participants will receive either a low dose, high dose, or placebo for 24 weeks. Researchers will measure changes …
Phase: PHASE2 • Sponsor: PhenoNet, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC